RETN and Alzheimer disease: However, resistin, a proved risk factor for both AD and atherosclerosis, was increased and β-OHB significantly reduced serum level of resistin in ApoE−/− + β-OHB mice, again confirming the possible therapeutic effect of β-OHB in both AD and atherosclerosis via inhibiting lipid-induced inflammations.